Loading clinical trials...
Loading clinical trials...
HELP Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX-2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
Conditions
Interventions
DX-2930 - 300mg/2wk
DX-2930 - 300mg/4wk
+2 more
Locations
41
United States
Clinical Research Center of Alabama, LLC
Birmingham, Alabama, United States
Medical Research of Arizona
Scottsdale, Arizona, United States
UC San Diego School of Medicine
San Diego, California, United States
AIRE Medical of Los Angeles
Santa Monica, California, United States
Allergy & Asthma Clinical Research
Walnut Creek, California, United States
IMMUNOe International Health & Research Centers
Centennial, Colorado, United States
Start Date
March 3, 2016
Primary Completion Date
April 13, 2017
Completion Date
April 13, 2017
Last Updated
June 2, 2021
NCT07298447
NCT06842823
NCT05396105
NCT05397431
NCT05469789
NCT07428499
Lead Sponsor
Shire
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions